Expert Perspective
Opinion
The body of evidence for Paxlovid therapy
For older patients, we should be thinking of why we should be using Paxlovid rather than the reason not to treat.
Opinion
I’m a physician battling long COVID. I can assure you it’s real
“I’ve also seen, firsthand, the frustration of navigating diagnosis and treatment. It’s given me a taste of what millions of other patients are...
Opinion
Ivermectin for COVID-19: Final nail in the coffin
Is this nice U.S. randomized trial enough to convince people that results from a petri dish don’t always transfer to humans, regardless of the...
Expert Perspective
The marked contrast in pandemic outcomes between Japan and the United States
Over time Japan has the least cumulative deaths per capita of any major country in the world.
Opinion
Why people lie about COVID
Of those surveyed, 41.6% admitted that they lied about COVID or didn’t adhere to COVID guidelines – a conservative estimate, if you ask me.
News
Three COVID scenarios that could spell trouble for the fall
Experts predict different scenarios, some more dire than others.
Opinion
Why can’t U.K. immunocompromised patients get Evusheld?
This is about collecting more data and being as rational as possible. Can we accelerate that process? Perhaps.
Opinion
Preparing for back to school amid monkeypox outbreak and ever-changing COVID landscape
The best defense that we currently have against COVID is the vaccine.
Opinion
Guidelines on GLP1RAs and continuous glucose monitors are among biggest news in diabetes
Some GLP1RAs have shown impressive weight reduction properties and cardiovascular benefits, says an endocrinologist.
Opinion
BA.4 and BA.5 subvariants are more evasive of antibodies, but not of cellular immunity
Our immunity in the United States is growing and is both from vaccination and natural infection.